🖼

Fig. 6 — Potent and specific MTH1 inhibitors targeting gastric cancer.

active
paper figure Created: 2026-04-21T18:29:40 By: paper_figures_tool Quality: 50% 🔗 External ID: paper-fig-paper-18d2a490986a-6
Fig. 6 — Potent and specific MTH1 inhibitors targeting gastric cancer.
Fig. 6Figure 6
The anti-proliferative activity of MI-743 on gastric cancer xenografts. Gastric cancer cells MGC-803 were transplanted subcutaneously to the right side of BALB-C nude mice. When most of the tumor volumes reached 100 mm 3 , the mice were treated with oil or compound MI-743(40 mg/kg, once a day) for 25 days. a The average tumor weight. b The tumor volumes were measured every 4 days. ( c ) The mice body weights were measured every 2 days. d , e The tumor tissues were collected and fixed in 4% buffered paraformaldehyde and paraffin-embedded for immunohistochemistry to detect the protein level of 8-oxo-dG and ATMpS1981 ( e ), H&E staining to observe the cell morphology and TUNEL staining to examine apoptosis status ( d ). Pictures for immunohistochemistry and H&E staining were originally captured at ×200 and ×400 magnification. Pictures for TUNEL staining were originally captured at ×400 magnification. f The mice major organs were collected and fixed in 4% buffered paraformaldehyde
PubMed: paper-18d2a490986a
Metadata
pmidpaper-18d2a490986a
captionThe anti-proliferative activity of MI-743 on gastric cancer xenografts. Gastric cancer cells MGC-803 were transplanted subcutaneously to the right side of BALB-C nude mice. When most of the tumor volu
image_urlhttps://www.ebi.ac.uk/europepmc/articles/PMC6547740/bin/41419_2019_1665_Fig6_HTML.jpg
paper_titlePotent and specific MTH1 inhibitors targeting gastric cancer.
figure_labelFig. 6
figure_number6
_schema_version1
source_strategypmc_api
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
View full evidence profile →
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.